Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne E M Kamphuis

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical Pharmacokinetics|April 4, 2024
Relative Bioavailability of Dolutegravir (DTG) and Emtricitabine/Tenofovir Alafenamide Fumarate (F/TAF) Administered as Paediatric Tablet Formulations in Healthy VolunteersLisanne A H Bevers, Anne E M Kamphuis, L C Wendy van der Wekken-Pas, et al.
Paediatric Drugs|October 22, 2024
Optimising Paediatric HIV Treatment: Recent Developments and Future DirectionsAnne E M Kamphuis, Alasdair Bamford, Alfredo Tagarro, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 16, 2025
Pharmacokinetic data of atazanavir/ritonavir in second-line treatment of children living with HIVAnne E M Kamphuis, Hylke Waalewijn, Roeland E Wasmann, et al.
AIDS (London, England)|August 29, 2025
Pharmacokinetics of lopinavir/ritonavir in second-line treatment of children living with HIV in the CHAPAS-4 trialAnne E M Kamphuis, Timo Kiezebrink, Hylke Waalewijn, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical Pharmacokinetics|April 4, 2024
Relative Bioavailability of Dolutegravir (DTG) and Emtricitabine/Tenofovir Alafenamide Fumarate (F/TAF) Administered as Paediatric Tablet Formulations in Healthy VolunteersLisanne A H Bevers, Anne E M Kamphuis, L C Wendy van der Wekken-Pas, et al.
Paediatric Drugs|October 22, 2024
Optimising Paediatric HIV Treatment: Recent Developments and Future DirectionsAnne E M Kamphuis, Alasdair Bamford, Alfredo Tagarro, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 16, 2025
Pharmacokinetic data of atazanavir/ritonavir in second-line treatment of children living with HIVAnne E M Kamphuis, Hylke Waalewijn, Roeland E Wasmann, et al.
AIDS (London, England)|August 29, 2025
Pharmacokinetics of lopinavir/ritonavir in second-line treatment of children living with HIV in the CHAPAS-4 trialAnne E M Kamphuis, Timo Kiezebrink, Hylke Waalewijn, et al.
Pageof 1